Alar Announced Buprenorphine Injectable, ALA-1000, Demonstrated Long-Term Efficacy and Favorable Safety Profile in Canine Osteoarthritis Pain Management

AI BRIEFING

• ⬤ ALA-1000 effective in osteoarthritis pain management for at least 1 month
• ⬤ Study demonstrates favorable safety profile with repeated use
• ⬤ Improves functional mobility in client-owned dogs with osteoarthritis